Exploring Cancer-Associated Thromboembolism Prognosis Biomarkers and Polymorphisms

Clinical trial NCT06065592 · UNKNOWN

Trial details

NCT number: NCT06065592
Sponsor: Lebanese University
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Cancer Solid Tumor Thromboembolism Cardiovascular Diseases Immune System Diseases Inflammatory Diseases Colon Cancer Breast Cancer Prostate Cancer Hepatocellular Carcinoma Lung Cancer Chemotherapy

Start date: 2019-02-01
Primary completion: 2024-12-01
Enrollment: 500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.